ADMA Biologics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
ADMA Biologics Inc Announces Pricing of Initial Public Offering
ADMA Biologics Inc announced the pricing of its initial public offering of 3,352,941 shares of its common stock at a public offering price of $8.50 per share. All of the shares of common stock are being offered by ADMA Biologics. In addition, ADMA Biologics has granted the underwriters a 30-day option to purchase up to an additional 502,941 shares of common stock at the same price to cover over-allotments, if any. The Company's shares are expected to begin trading on The OTCQB Marketplace on October 17, 2013 under the ticker symbol 'ADMA.' The offering is expected to close on October 22, 2013, subject to customary closing conditions. Oppenheimer & Co. is acting as sole book-running manager for the offering. Ladenburg Thalmann & Co. Inc., Maxim Group LLC and Laidlaw & Company (UK) Ltd. are acting as co-managers.
Latest Developments for ADMA Biologics Inc
- Share this
- Digg this